Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-22

FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' generic drospirenone and ethinyl estradiol combination tablet under an original application (ANDA 211944).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DROSPIRENONE AND ETHINYL ESTRADIOL (drospirenone and ethinyl estradiol)

Snippet

ORIG AP for DROSPIRENONE AND ETHINYL ESTRADIOL (DROSPIRENONE AND ETHINYL ESTRADIOL)